Ovid Therapeutics to Present at the 12th International Epilepsy Colloquium


First scientific presentation of OV-935 (TAK-935) safety and tolerability data in developmental and epileptic encephalopathies from the Phase 1b/2a clinical ... Lees verder

Bron: ANP Pers support
Tags:
Geplaatst: 23 mei 2019 - 23:06